234 related articles for article (PubMed ID: 28702272)
1. Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma.
Epeldegui M; Martínez-Maza O
For Immunopathol Dis Therap; 2015; 6(1-2):79-90. PubMed ID: 28702272
[TBL] [Abstract][Full Text] [Related]
2. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584
[TBL] [Abstract][Full Text] [Related]
3. Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma.
Vendrame E; Martínez-Maza O
J Proteome Res; 2011 Jan; 10(1):113-9. PubMed ID: 20886858
[TBL] [Abstract][Full Text] [Related]
4. TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosis.
Guo Y; Siewe B; Epeldegui M; Detels R; Landay AL; Martínez-Maza O
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):204-10. PubMed ID: 23722608
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk.
Vendrame E; Hussain SK; Breen EC; Magpantay LI; Widney DP; Jacobson LP; Variakojis D; Knowlton ER; Bream JH; Ambinder RF; Detels R; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):343-9. PubMed ID: 24220912
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.
Epeldegui M; Magpantay L; Guo Y; Halec G; Cumberland WG; Yen PK; Macatangay B; Margolick JB; Rositch AF; Wolinsky S; Martinez-Maza O; Hussain SK
AIDS; 2018 Apr; 32(7):945-954. PubMed ID: 29424776
[TBL] [Abstract][Full Text] [Related]
7. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.
Hussain SK; Hessol NA; Levine AM; Breen EC; Anastos K; Cohen M; D'Souza G; Gustafson DR; Silver S; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2084-93. PubMed ID: 24045923
[TBL] [Abstract][Full Text] [Related]
8. AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment.
Carbone A
Hum Pathol; 2002 Apr; 33(4):392-404. PubMed ID: 12055673
[TBL] [Abstract][Full Text] [Related]
9. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
[TBL] [Abstract][Full Text] [Related]
10. Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL.
Epeldegui M; Conti DV; Guo Y; Cozen W; Penichet ML; Martínez-Maza O
Sci Rep; 2019 Jun; 9(1):9371. PubMed ID: 31253857
[TBL] [Abstract][Full Text] [Related]
11. Circulating mediators of inflammation and immune activation in AIDS-related non-hodgkin lymphoma.
Nolen BM; Breen EC; Bream JH; Jenkins FJ; Kingsley LA; Rinaldo CR; Lokshin AE
PLoS One; 2014; 9(6):e99144. PubMed ID: 24922518
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.
Widney D; Gundapp G; Said JW; van der Meijden M; Bonavida B; Demidem A; Trevisan C; Taylor J; Detels R; Martínez-Maza O
Clin Immunol; 1999 Nov; 93(2):114-23. PubMed ID: 10527687
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of HIV-associated non-Hodgkin lymphoma.
Killebrew D; Shiramizu B
Curr HIV Res; 2004 Jul; 2(3):215-21. PubMed ID: 15279585
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
[TBL] [Abstract][Full Text] [Related]
16. AIDS-Associated Malignancies.
Vangipuram R; Tyring SK
Cancer Treat Res; 2019; 177():1-21. PubMed ID: 30523619
[TBL] [Abstract][Full Text] [Related]
17. The Role of Microbial Translocation and Immune Activation in AIDS-Associated Non-Hodgkin Lymphoma Pathogenesis: What Have We Learned?
Epeldegui M; Hussain SK
Crit Rev Immunol; 2020; 40(1):41-51. PubMed ID: 32421978
[TBL] [Abstract][Full Text] [Related]
18. Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy.
Thirlwell C; Sarker D; Stebbing J; Bower M
Clin Lymphoma; 2003 Sep; 4(2):86-92. PubMed ID: 14556679
[TBL] [Abstract][Full Text] [Related]
19. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
[TBL] [Abstract][Full Text] [Related]
20. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
